Skip to content
Search

Latest Stories

India's financial hub Mumbai set to extend coronavirus lockdown

India's financial hub Mumbai is set to extend lockdown measures until at least April 30 as authorities race to expand testing to stem the spread of coronavirus in the city, three senior officials said.

A 21-day nationwide lockdown that prime minister Narendra Modi declared in late March to fight the epidemic is officially set to end on April 14.


But Mumbai, with a population of more than 20 million, has become India's coronavirus epicentre. The metropolis and its suburbs have reported 782 positive cases and 50 deaths, the latest health bulletin said on Wednesday.

"In Mumbai cases are rising too fast. In just 24 hours 100 cases were reported on Tuesday," said a senior state government official, adding that the trend was alarming and at least another two weeks of lockdown were necessary to stop the virus from spreading in one of the world's most densely populated cities.

Mumbai municipal authority and the state government of Maharashtra, of which Mumbai is the capital, both declined to comment.

The state government has yet to announce the extension as it is assessing the situation in satellite city Pune and Nagpur, a commercial hub.

As of Wednesday morning, Maharashtra accounted for 1,078, or more than 20 per cent of India's 5,194 confirmed cases. It has also recorded 64 deaths, or 43 per cent of India's 149 fatalities.

A second senior government official in Mumbai said the "only solution" to deal with the grave public health emergency was to extend the lockdown by two weeks.

Both officials requested anonymity as they were not cleared to discuss the matter with the media.

A federal home ministry official said several state governments, including Maharastra, had proposed an extension of the lockdown, and these requests were being considered by Modi's office.

In April, health officials in Mumbai witnessed a worrying trend of patients who had no initial symptoms but later tested positive, infecting medical staff and forcing hospitals to close partially.

The state government had identified companies to manufacture rapid test kits which could be used in slum districts and government offices to test people with mild symptoms.

"We are thinking to use rapid test kits, but these kits need certification," said Uddhav Thackeray, the state chief minister. "The moment they will be approved and made available, we will start using them."

Thousands of female health workers trained to administer the polio vaccine will be recruited to use the mobile test kits in the next two weeks.

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less